Form 4: Atlassian CTO Rajeev Bashyam Sells 3,500 Shares Under 10b5-1 Plan
SEC Form 4
Atlassian's Chief Technology Officer, Rajeev Bashyam, sold 3,500 shares of Class A Common Stock at $320.01 per share on January 31, 2025, as part of a pre-arranged trading plan.
Summary
- Rajeev Bashyam, the Chief Technology Officer of Atlassian, sold 3,500 shares of Class A Common Stock.
- The sale occurred on January 31, 2025, at a price of $320.01 per share.
- This transaction was executed under a Rule 10b5-1 trading plan adopted on November 29, 2023.
- Following the transaction, Bashyam directly owns 186,989 shares of Atlassian Class A Common Stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction under a pre-arranged trading plan, with no indication of positive or negative sentiment.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, although this sale was pre-planned.
Industry Context
This is a routine transaction for executives who often use 10b5-1 plans to manage their stock sales, and is not unusual in the tech industry.
Comparison to Industry Standards
- Many tech executives use 10b5-1 plans to sell shares, so this is a common practice.
- The sale is not unusual compared to other similar transactions by executives at comparable companies.
- The volume of shares sold is not significant relative to the total shares outstanding for Atlassian.
Stakeholder Impact
- The impact on shareholders is likely to be minimal, as the sale was pre-planned and not a large portion of the total shares outstanding.
Key Dates
| Date | Description |
|---|---|
| 2023-11-29 | Date the Rule 10b5-1 trading plan was adopted by Rajeev Bashyam. |
| 2025-01-31 | Date of the stock sale transaction. |
| 2025-02-03 | Date the Form 4 was signed. |
Keywords
Atlassian, Rajeev Bashyam, stock sale, Rule 10b5-1, insider trading, Class A Common Stock, executive transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.